Signs of dehydration requiring immediate attention include dark yellow or amber urine, significant dizziness when standing, rapid heartbeat, confusion, or inability to keep any fluids down for more than 12 hours
Histopathological examination revealed restoration of hepatic architecture, with nearly regular cords and sinusoids and a marked decline in lipid droplets and lymphocytic infiltration
The Evidence Multiple large cardiovascular outcome trials have demonstrated GLP-1 medications reduce heart attacks, strokes, and cardiovascular death: SUSTAIN-6 (semaglutide): 26% reduction in major adverse cardiovascular events (MACE) in patients with Type 2 diabetes and high cardiovascular risk
In the GLP-1RA family of agents, the results of CVOT have been inconsistent
on 2025-12-10 J'en prend en ce moment, bon produit